Kevin Moulder

521 total citations
14 papers, 413 citations indexed

About

Kevin Moulder is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Immunology and Allergy. According to data from OpenAlex, Kevin Moulder has authored 14 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 5 papers in Immunology and Allergy. Recurrent topics in Kevin Moulder's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Cell Adhesion Molecules Research (5 papers) and T-cell and B-cell Immunology (4 papers). Kevin Moulder is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Cell Adhesion Molecules Research (5 papers) and T-cell and B-cell Immunology (4 papers). Kevin Moulder collaborates with scholars based in United States, United Kingdom and Austria. Kevin Moulder's co-authors include Ethan M. Shevach, M W Steward, J E Coligan, K Roberts, Gary Christie, Paul R. Murdock, M. Laird Forrest, K.H. Jennings, Joanne C. Cooper and Hannah J. Gould and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and Journal of Controlled Release.

In The Last Decade

Kevin Moulder

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Moulder United States	11	221	128	112	106	54	14	413
Yinan Lan United States	5	182 0.8×	74 0.6×	55 0.5×	117 1.1×	40 0.7×	5	443
Jeffrey L. Haddox United States	14	86 0.4×	198 1.5×	36 0.3×	121 1.1×	76 1.4×	28	521
Y P Yung United States	7	318 1.4×	62 0.5×	98 0.9×	139 1.3×	26 0.5×	11	435
Gerolamo Chiappino Italy	7	198 0.9×	136 1.1×	17 0.2×	175 1.7×	27 0.5×	9	533
Su Yu United States	9	118 0.5×	45 0.4×	22 0.2×	222 2.1×	48 0.9×	14	485
P. L. van Soest Netherlands	10	211 1.0×	99 0.8×	25 0.2×	128 1.2×	66 1.2×	18	430
Krisztina Kerekes Hungary	14	273 1.2×	27 0.2×	27 0.2×	206 1.9×	29 0.5×	30	510
Tom J.M. Molenaar Netherlands	10	78 0.4×	114 0.9×	64 0.6×	192 1.8×	28 0.5×	14	368
K G Sundqvist Sweden	10	177 0.8×	25 0.2×	111 1.0×	169 1.6×	66 1.2×	20	436
Roslyn V. Gibbs United Kingdom	12	112 0.5×	21 0.2×	60 0.5×	177 1.7×	58 1.1×	19	444

Countries citing papers authored by Kevin Moulder

Since Specialization

Citations

This map shows the geographic impact of Kevin Moulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Moulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Moulder more than expected).

Fields of papers citing papers by Kevin Moulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Moulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Moulder. The network helps show where Kevin Moulder may publish in the future.

Co-authorship network of co-authors of Kevin Moulder

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Moulder. A scholar is included among the top collaborators of Kevin Moulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Moulder. Kevin Moulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Moulder, Kevin, et al.. (2019). Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines. Bioorganic & Medicinal Chemistry Letters. 30(2). 126788–126788. 5 indexed citations

Groer, Chad E., Kevin Moulder, Aric Huang, et al.. (2019). Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Journal of Controlled Release. 306. 165–176. 68 indexed citations

Salimu, Josephine, Pascal Merchiers, Beatriz Goyenechea, et al.. (2018). Abstract 2787: Generation of first-in-class anti-CD25 antibodies depleting Treg without interfering with IL2 signalling for cancer therapies. Cancer Research. 78(13_Supplement). 2787–2787. 1 indexed citations

Leung, Kin-Mei, Sarah Batey, Phil Jones, et al.. (2015). A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis. Molecular Therapy. 23(11). 1722–1733. 25 indexed citations

Woisetschläger, M., Susanne Wiederkum, Herta Steinkellner, et al.. (2014). In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her‐2/neu binding sites. Biotechnology Journal. 9(6). 844–851. 11 indexed citations

Traxlmayr, Michael W., Elisabeth Lobner, Susanne Wiederkum, et al.. (2012). Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display. Protein Engineering Design and Selection. 26(4). 255–265. 28 indexed citations

Cooper, Joanne C., et al.. (2003). Alefacept selectively promotes NK cell‐mediated deletion of CD45R0⁺ human T cells. European Journal of Immunology. 33(3). 666–675. 50 indexed citations

Karagiannis, Sophia N., K.H. Jennings, Paul R. Murdock, et al.. (2001). Endocytosis and recycling of the complex between CD23 and HLA‐DR in human B cells. Immunology. 103(3). 319–331. 57 indexed citations

Christie, Gary, A. D. Barton, Brian Bolognese, et al.. (1997). IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII). European Journal of Immunology. 27(12). 3228–3235. 39 indexed citations

10.

Moulder, Kevin, et al.. (1993). CD23‐mediated homotypic cell adhesion: The role of proteolysis. European Journal of Immunology. 23(9). 2066–2071. 10 indexed citations

11.

Moulder, Kevin, K Roberts, Ethan M. Shevach, & J E Coligan. (1991). The mouse vitronectin receptor is a T cell activation antigen.. The Journal of Experimental Medicine. 173(2). 343–347. 45 indexed citations

12.

Moulder, Kevin, Frits Koning, A Elbe, et al.. (1989). Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies.. The Journal of Experimental Medicine. 169(6). 2173–2190. 44 indexed citations

13.

Moulder, Kevin & M W Steward. (1989). Capillary-localized low-affinity antibody-antigen complexes act as a focus for the deposition of high-affinity complexes.. PubMed. 77(2). 275–80. 1 indexed citations

14.

Moulder, Kevin & M W Steward. (1989). Experimental zinc deficiency: effects on cellular responses and the affinity of humoral antibody.. PubMed. 77(2). 269–74. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact